Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type

  • An Erratum to this article was published on 01 August 2006

Abstract

Methylmalonic aciduria and homocystinuria, cblC type (OMIM 277400), is the most common inborn error of vitamin B12 (cobalamin) metabolism, with about 250 known cases. Affected individuals have developmental, hematological, neurological, metabolic, ophthalmologic and dermatologic clinical findings1. Although considered a disease of infancy or childhood, some individuals develop symptoms in adulthood2. The cblC locus was mapped to chromosome region 1p by linkage analysis3. We refined the chromosomal interval using homozygosity mapping and haplotype analyses and identified the MMACHC gene. In 204 individuals, 42 different mutations were identified, many consistent with a loss of function of the protein product. One mutation, 271dupA, accounted for 40% of all disease alleles. Transduction of wild-type MMACHC into immortalized cblC fibroblast cell lines corrected the cellular phenotype. Molecular modeling predicts that the C-terminal region of the gene product folds similarly to TonB, a bacterial protein involved in energy transduction for cobalamin uptake.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: MMACHC location, structure and mutations.
Figure 2: Transduction of fibroblast cells with MMACHC.
Figure 3: Haplotypes inferred from 54 CEPH individuals and from 99 cblC individuals homozygous for MMACHC mutations.
Figure 4: Conservation and homology-based modeling of MMACHC.

Accession codes

Accessions

GenBank/EMBL/DDBJ

Protein Data Bank

Change history

  • 30 June 2006

    The error has been corrected in the PDF version of this article.

References

  1. 1

    Rosenblatt, D. & Fenton, W.A. Inherited disorders of folate and cobalamin transport and metabolism in The Metabolic & Molecular Bases of Inherited Disease Vol. 3, 3897–3933 (McGraw-Hill, New York, 2001).

  2. 2

    Rosenblatt, D.S. et al. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J. Inherit. Metab. Dis. 20, 528–538 (1997).

  3. 3

    Atkinson, J. Genetic Mapping of Cobalamin C Deficiency: Linkage to Chromosome 1p32–34. Thesis. Univ. of Toronto, (2003).

  4. 4

    Homocysteine in Health and Disease (eds. Carmel, R. & Jacobsen, D.W.) (Cambridge Univ. Press, Cambridge, 2001).

  5. 5

    Andersson, H.C. & Shapira, E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J. Pediatr. 132, 121–124 (1998).

  6. 6

    Mellman, I., Willard, H.F., Youngdahl-Turner, P. & Rosenberg, L.E. Cobalamin coenzyme synthesis in normal and mutant fibroblasts: evidence for a processing enzyme activity deficient in cblC cells. J. Biol. Chem. 254, 11847–11853 (1979).

  7. 7

    Templeton, A.R. et al. Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am. J. Hum. Genet. 66, 69–83 (2000).

  8. 8

    Stephens, M., Smith, N.J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978–989 (2001).

  9. 9

    Stephens, M. & Donnelly, P. A comparison of Bayesian methods for haplotype reconstruction. Am. J. Hum. Genet. 73, 1162–1169 (2003).

  10. 10

    Maquat, L.E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat. Rev. Mol. Cell Biol. 5, 89–99 (2004).

  11. 11

    Drennan, C.L., Huang, S., Drummond, J.T., Matthews, R.G. & Ludwig, M.L. How a protein binds B12: a 3.0 A X-ray structure of B12 -binding domains of methionine synthase. Science 266, 1669–1674 (1994).

  12. 12

    Chang, C., Mooser, A., Plückthun, A. & Wlodawer, A. Crystal structure of the dimeric C-terminal domain of TonB reveals a novel fold. J. Biol. Chem. 276, 27535–27540 (2001).

  13. 13

    Ködding, J. et al. Crystal structure of a 92-residue C-terminal fragment of TonB from Escherichia coli reveals significant conformational changes compared to structures of smaller TonB fragments. J. Biol. Chem. 280, 3022–3028 (2005).

  14. 14

    Peacock, R.S., Weljie, A.M., Howard, S.P., Price, F.D. & Vogel, H.J. The solution structure of the C-terminal domain of TonB and interaction studies with TonB box peptides. J. Mol. Biol. 345, 1185–1197 (2005).

  15. 15

    Sali, A. & Blundell, T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993).

  16. 16

    Laskowski, R.A., MacArthur, M.W. & Thornton, J.M. PROCHECK: a program to check the stereochemical quality of protein structure. J. Appl. Crystallogr. 26, 283–291 (1993).

  17. 17

    Kleywegt, G.J. Experimental assessment of differences between related protein crystal structures. Acta Crystallogr. D Biol. Crystallogr. 55, 1878–1884 (1999).

  18. 18

    Bell, P.E., Nau, C.D., Brown, J.T., Konisky, J. & Kadner, R.J. Genetic suppression demonstrates interaction of TonB protein with outer membrane transport proteins in Escherichia coli. J. Bacteriol. 172, 3826–3829 (1990).

  19. 19

    Cadieux, N. & Kadner, R.J. Site-directed disulfide bonding reveals an interaction site between energy-coupling protein TonB and BtuB, the outer membrane cobalamin transporter. Proc. Natl. Acad. Sci. USA 96, 10673–10678 (1999).

  20. 20

    Rosenblatt, D.S., Hosack, A., Matiaszuk, N.V., Cooper, B.A. & Laframboise, R. Defect in vitamin B12 release from lysosomes: newly described inborn error of vitamin B12 metabolism. Science 228, 1319–1321 (1985).

  21. 21

    Pezacka, E.H. & Rosenblatt, D.S. Intracellular metabolism of cobalamin. Altered activities of β-axial-ligand transferase and microsomal cob(III)alamin reductase in cblC and cblD fibroblasts in Advances in Thomas Addison's Diseases 315–323 (Journal of Endocrinology, Bristol, UK, 1994).

  22. 22

    Brudno, M. et al. LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res. 13, 721–731 (2003).

  23. 23

    Watkins, D. Cobalamin metabolism in methionine-dependent human tumour and leukemia cell lines. Clin. Invest. Med. 21, 151–158 (1998).

  24. 24

    Watkins, D., Matiaszuk, N. & Rosenblatt, D.S. Complementation studies in the cblA class of inborn error of cobalamin metabolism: evidence for interallelic complementation and for a new complementation class (cblH). J. Med. Genet. 37, 510–513 (2000).

  25. 25

    Ewing, B., Hillier, L., Wendl, M.C. & Green, P. Base-calling of automated sequencer traces using Phred I. Accuracy assesment. Genome Res. 8, 175–185 (1998).

  26. 26

    Gordon, D., Abajian, C. & Green, P. Consed: A graphical tool for sequence finishing. Genome Res. 8, 195–202 (1998).

  27. 27

    Miller, A.D. & Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895–2902 (1986).

  28. 28

    Yao, J. & Shoubridge, E.A. Expression and functional analysis of SURF1 in Leigh syndrome patients with cytochrome C oxidase deficiency. Hum. Mol. Genet. 8, 2541–2549 (1999).

  29. 29

    Horton, P. & Nakai, K. Better prediction of protein cellular localization sites with the k nearest neighbors classifier. Proc. Int. Conf. Intell. Syst. Mol. Biol. 5, 147–152 (1997).

Download references

Acknowledgements

We dedicate this work to the memory of J.C. Tirone. We thank the clinicians who provided patient samples and clinical information; N. Matiaszuk and J. Lavallée for complementation analysis; A. Verner and G. Genaud for microsatellite genotyping; N. Roslin for microsatellite analysis; M. Galvez and J. Liu for laboratory work; G. Leveque, T.A. Johns and D. Roquis for technical assistance; S. Froese, L. Worgan, K. Niles and A. Montpetit for discussion and J. Kashul and D. Ellis for editing. This research was supported by grants from the March of Dimes Birth Defects Foundation (6-FY01-11), Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation to the Montreal Integrated Genomics Group for Research on Infectious Pathogens, and the Network of Centres of Excellence Program—the Canadian Genetic Diseases Network. D.S.R. is a principal investigator in the CIHR Group in Medical Genetics. This is a publication of the Hess B. and Diane Finestone Laboratory in Memory of Jacob and Jenny Finestone.

Author information

Correspondence to David S Rosenblatt.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

One affected child and one affected fetus were diagnosed with cblC. (PDF 250 kb)

Supplementary Table 1

Markers used for homozygosity mapping and haplotype analyses. (PDF 15 kb)

Supplementary Table 2

Primers used to amplify the MMACHC gene from gDNA and cDNA. (PDF 54 kb)

Supplementary Note (PDF 36 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lerner-Ellis, J., Tirone, J., Pawelek, P. et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 38, 93–100 (2006). https://doi.org/10.1038/ng1683

Download citation

Further reading